Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab.
Montagut
Clara
C
Grau
Juan J
JJ
Grimalt
Ramon
R
Codony
Jordi
J
Ferrando
Juan
J
Albanell
Joan
J
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068818:Cetuximab; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008297:Male; D018307:Neoplasms, Squamous Cell / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab